Sulindac

Sulindac is a non-steroidal anti-inflammatory drug (NSAID) used for the treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gout. Mediocon Inc supplies pharmaceutical-grade Sulindac conforming to IP / BP / EP / USP specifications.

As a prodrug, Sulindac is converted in vivo to its active sulfide metabolite, which inhibits cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin synthesis and resulting in anti-inflammatory, analgesic, and antipyretic effects.

Key Features

• High-purity pharmaceutical grade API
• IP / BP / EP / USP compliant
• Full CoA and MSDS documentation
• GMP certified manufacturing facility

Applications

• Anti-inflammatory tablet formulations
• Arthritis therapy preparations
• NSAID pharmaceutical manufacturing
• Analgesic and antipyretic formulations

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings

Parameter	Specification
Assay	NLT 98.0%
Loss on Drying	NMT 0.5%
Heavy Metals	NMT 20 ppm
Residue on Ignition	NMT 0.1%
Microbial Limits	Complies with pharmacopoeia
Identification	IR, HPLC Compliant
Mfg Date	MAR 2025
Exp Date	FEB 2031
Packing	25 kg HDPE drums / as per requirement